Skip to content

Danish Life Sciences Forum

Danish Life Sciences Forum Brand


The Danish Trade Council, Lundbeck Canada Inc., Novo Nordisk Canada Inc., and LEO Pharma Inc. Canada.


Formalized in March 2018, the Danish Life Sciences Forum is a group of three Danish pharmaceutical affiliates in Canada (Novo Nordisk Canada, Lundbeck Canada, and LEO Pharma) who all share a similar interest in the long-term sustainability of the innovative life sciences industry in Canada.

Danish Life Sciences Forum members are all foundation-based companies. These foundations have a mandate to develop social and economic benefits to all and not just the shareholders. A substantial portion of their revenue is redirected to support research and education as well as contribute to civil society, culture, and the economy.

The Forum is committed to engaging with public and private sector stakeholders in Canada to help ensure that the life sciences industry continues to be an important source of jobs, economic growth, and improved health outcomes for Canadians.

Opportunities and Challenges

Denmark and Canada not only share a physical 4,000 km border, but they also have many other similarities, including standard of living, business culture, societal values, as well as a general ambition to be ahead of the curve when it comes to finding innovative solutions to problems.

We believe that given our similarities, we have a lot that we can learn from each other, including our approaches to creating a business-friendly environment and regulatory framework that allows for innovation, better access, and growth in the life sciences sector.


contact uS:

Robby Spring

Trade Advisor

Healthcare and Life Sciences

Tel.: 001 416 640 1302